Shop by goal

Popular compounds

Research resources

Recently viewed

How-to guides

Ipamorelin: HGH / Somatropin research guide

Not medical advice. Ipamorelin is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

What Ipamorelin is

Ipamorelin is a growth-hormone secretagogue studied for pituitary signalling and pulse-like GH release patterns in animals -distinct from exogenous GH itself.

One-paragraph overview from our research datasheet — still scientific, but faster to read than the full mechanism list below.

Ipamorelin, first selective growth hormone secretagogue with GHRH-like GH specificity and no significant ACTH, cortisol, or prolactin stimulation.

Quick takeaways

  • Research often compares it with other GHRP-class peptides for selectivity and side-effect profiles in models.
  • Research contexts

    Peer-reviewed literature typically discusses Ipamorelin in specific experimental settings. The points below reflect how the scientific community frames this compound—not as health claims, but as the research questions being asked.

    Research vs. personal use: Literature describes experiments in controlled lab and animal models. This is distinct from any real-world use; our products are for laboratory research only.

    Typical study contexts

  • Rodent studies typically measure GH pulses and downstream IGF markers rather than long-term human outcomes.
  • GH-axis research is tightly regulated in medicine; the scientific interest is endocrine mechanism, not lifestyle optimisation.
  • Pituitary GH release patterns, receptor signalling, and metabolic readouts in compliant animal research.
  • Comparisons between secretagogues and exogenous GH in model organisms, focusing on endocrine biology.
  • Peer-reviewed preclinical work sometimes describes experiments that track whether first-in-class selective GHS-R1a agonist with GH specificity matching GHRH, no cortisol or ACTH elevation
  • Peer-reviewed preclinical work sometimes describes experiments that track whether does not stimulate prolactin secretion distinguishing it from hexarelin, GHRP-2, and GHRP-6
  • Peer-reviewed preclinical work sometimes describes experiments that track whether in vitro EC50 of 1.3 nM for pituitary GH release comparable to GHRP-6 potency
  • Peer-reviewed preclinical work sometimes describes experiments that track whether activates phospholipase C/IP3/calcium cascade selectively on somatotroph cells
  • Why HGH / Somatropin research matters

    Growth-hormone axis peptides are researched for how they signal through the GH/IGF pathway in animals and cells. Studies focus on endocrine biology and metabolism, not on prescribing or outcomes in people.

    Mechanisms (technical review)

    Our datasheet lists mechanistic themes observed in preclinical work. These are research endpoints, not health claims. They help scientists understand and compare pathways.

  • First-in-class selective GHS-R1a agonist with GH specificity matching GHRH, no cortisol or ACTH elevation
  • Does not stimulate prolactin secretion distinguishing it from hexarelin, GHRP-2, and GHRP-6
  • In vitro EC50 of 1.3 nM for pituitary GH release comparable to GHRP-6 potency
  • Activates phospholipase C/IP3/calcium cascade selectively on somatotroph cells
  • Synergistic GH amplification when combined with GHRH analogues (CJC-1295, sermorelin)
  • Favorable safety profile demonstrated in phase II clinical trials at supratherapeutic doses
  • Lab handling & preparation

    Storage requirements: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. · Learn best practices in our detailed storage guide.

    Research dosing context: Literature typically discusses 100–300 mcg subcutaneously · 1–3 times daily, typically pre-sleep · Terminal t½ ≈ 2 h; clearance 0.078 L/h/kg; Vd = 0.22 L/kg; Tmax (GH peak) ≈ 40 min; SC bioavailability ~95%; intranasal bioavailability ~20%; 60–80% recovered as intact peptide in urine/bile indicating moderate metabolic resistance (Gobburu et al., Pharmaceutical Research, 1999).

    Preparation steps: Follow our detailed reconstitution guide, use the calculator tool for volume confirmation, and always verify purity with the COA reading guide.

    Common Questions People Are Asking

    What is ipamorelin?

    Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) that selectively activates the ghrelin/growth-hormone-secretagogue receptor (GHSR), prompting the pituitary to release growth hormone. It is one of the most selective GH secretagogues studied and is supplied as a lyophilised research-grade powder for laboratory use only.

    What does ipamorelin do?

    In research models ipamorelin stimulates a clean, pulse-like release of growth hormone from the pituitary by acting on the GHSR receptor — without the cortisol, ACTH or prolactin spikes seen with GHRP-2/GHRP-6. These are findings in cell and animal models; no human therapeutic effect is implied.

    What is ipamorelin used for?

    In the research literature ipamorelin is used as a tool compound to study the growth-hormone axis, GH/IGF-1 signalling, body-composition and recovery endpoints, often alongside a GHRH analogue such as CJC-1295. New-U supplies it strictly for in-vitro and animal-model research; it is not for human use.

    Is ipamorelin safe?

    In published animal studies ipamorelin has been well tolerated with a notably selective profile (minimal cortisol/prolactin effect), but there are no controlled human safety trials, so human safety is not established. It is a research compound, not a medicine; New-U makes no human-use claims and supplies it for laboratory research only.

    Is ipamorelin FDA approved?

    No. Ipamorelin is an investigational research peptide and is not approved by the FDA, EMA, or any other regulator for human therapeutic use. It is sold strictly for preclinical and in-vitro research.

    Why is ipamorelin considered "cleaner" than GHRP-2 or GHRP-6?

    GHRP-2 and GHRP-6 both activate the ghrelin receptor but also trigger noticeable increases in cortisol, ACTH, and prolactin at GH-releasing doses. Ipamorelin does not - even at doses hundreds of times above its GH-releasing threshold, those secondary pituitary effects remain flat.

    Can ipamorelin be combined with CJC-1295?

    Yes - this is the most common research stack in the GHRP family. Ipamorelin activates the ghrelin receptor while CJC-1295 activates the GHRH receptor, and the two mechanisms produce supra-additive GH release. The pairing is used to mimic physiologic pulsatile GH secretion.

    Does ipamorelin cause hunger like GHRP-6?

    Ipamorelin produces far weaker orexigenic effects than GHRP-6 in comparative studies. Its ghrelin-receptor selectivity is tuned toward somatotroph activation rather than hypothalamic appetite signalling, so appetite stimulation is typically minimal in research protocols.

    Does ipamorelin affect sleep?

    A large share of the body's natural growth-hormone output occurs during deep, slow-wave sleep, which is why ipamorelin is frequently studied with pre-sleep timing — to line its short, clean GH pulse up with that nocturnal surge. The GH/IGF-1 axis is closely tied to slow-wave sleep in the literature, so sleep-quality and recovery endpoints are common in research designs. These are research-context observations; ipamorelin is supplied for laboratory research only and is not for human use.

    How should ipamorelin be stored?

    Keep the lyophilised powder frozen at −20 °C until reconstitution. After mixing with bacteriostatic water, refrigerate at 1-6 °C and protect from light. Ipamorelin is stable in solution within the normal peptide-handling window.

    How much does ipamorelin cost?

    Research-grade ipamorelin is priced per vial and sold by New-U in sealed 10-vial research packs, with the per-mg cost falling on larger vials. Every pack is >99% HPLC-verified with a batch-linked Certificate of Analysis. See the New-U ipamorelin page for current per-vial pricing; supplied for laboratory research use only.

    What does a CJC-1295 + ipamorelin research cycle cost per month?

    The most-studied GH-axis pairing combines ipamorelin (a ghrelin-receptor agonist) with CJC-1295 (a GHRH analogue). Monthly research cost depends on the amounts and frequency a protocol uses for each vial; because both are sold in 10-vial packs at per-vial pricing, larger vials lower the per-mg cost of the pairing. New-U publishes per-vial pricing on each product page - this is research-supply cost context, not a human-use dosing or cost recommendation.

    What ipamorelin dosage is used in research?

    Published research protocols describe microgram-range subcutaneous amounts, often once to a few times daily, sometimes timed to the natural nocturnal GH pulse. New-U publishes this as descriptive research context only - it is not a dosing instruction, and ipamorelin is supplied strictly for laboratory research, not human use.

    What effects are studied with ipamorelin?

    Ipamorelin is studied for selective growth-hormone release and downstream GH/IGF-1-axis endpoints (body composition, recovery, sleep) without the cortisol, prolactin or strong appetite signals seen with GHRP-6. These are research findings; New-U makes no therapeutic claims and sells ipamorelin for research use only.

    How does ipamorelin compare to sermorelin and hexarelin?

    All three raise growth hormone but through different receptors/scaffolds: ipamorelin is a clean, selective ghrelin-receptor (GHSR) agonist; sermorelin is a GHRH analogue acting upstream on the pituitary; hexarelin is a more potent GHRP-6-type GHSR agonist with added CD36 cardiac activity but more cortisol/prolactin. See our Ipamorelin vs Sermorelin and Hexarelin vs Ipamorelin research comparisons for the full breakdown.

    What happens if you stop taking peptides?

    For growth-hormone-secretagogue peptides such as ipamorelin, the published research is informative: these compounds work by transiently stimulating the body's own GH pulses rather than replacing a hormone, so when administration stops the endogenous GH/IGF-1 axis returns toward its untreated baseline without the prolonged suppression seen after exogenous HGH. Effects observed during a study taper off as the short-acting peptide clears. These are research-model observations — ipamorelin is supplied for laboratory research only and is not for human use.

    Is this page medical advice? Can I use Ipamorelin for my health?

    No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

    Where do I find Ipamorelin specs, purity certificates and pricing?

    Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

    Related peptide guides

    Other compounds researchers often read about alongside Ipamorelin.

  • HGH 191 AA - companion guide
  • Tesamorelin - companion guide
  • Sermorelin - companion guide
  • HGH Fragment 176-191 - companion guide
  • Scientific sources & further reading

    Primary literature and registries for Ipamorelin, plus mainstream coverage of the peptide category. Research use only - not medical advice.

    Databases & literature:

  • PubMed: peer-reviewed literature on Ipamorelin
  • ClinicalTrials.gov: registered studies on Ipamorelin
  • Ipamorelin: Wikipedia
  • Peptides in the news:

  • WebMD: consumer health reference
  • BBC News: Health
  • CNN Health: “Peptides: what to know about the wellness trend”
  • Sky News: “Can peptides make America healthy again?”
  • Sky News: “Inside the exploding US peptides craze” (video)
  • Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”
  • Sky News Australia: “Backyard peptide boom sparks alarm” (video)
  • Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”
  • Ready to order? View full product specs

    Access concentration, batch info, variants, and current pricing on our shop.

    Also known as: NNC 26-0161, Ipamorelin Acetate, IPA, Selective GH Secretagogue

    Premium research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical with a Certificate of Analysis on every lot. Shipped lab-direct, discreet and cold-chain, worldwide. For laboratory research use only.

    Shop

  • All Peptides
  • Fat-Loss Peptides
  • Skin & Anti-Aging
  • Stacks & Protocols
  • Compare Vials
  • Peptide 101
  • Learn

  • Research Blog
  • How-To Guides
  • Certificates of Analysis
  • Community Forum
  • Company

  • About Us
  • Contact
  • FAQ
  • Affiliate Program
  • VIP Club
  • Support

  • Shipping & Delivery
  • Pay with Crypto
  • Live Crypto Prices
  • Refund Policy
  • Privacy
  • Terms
  • Ways to Pay

  • Google Pay
  • Apple Pay
  • Venmo
  • PayPal
  • Crypto
  • Cash App
  • Credit Card
  • SEPA
  • Shop by Compound

  • BPC-157
  • TB-500
  • GHK-Cu
  • Tesamorelin
  • Retatrutide
  • Semaglutide
  • Tirzepatide
  • CJC-1295 (without DAC)
  • View all compounds →
  • Shop by Goal

  • Fat Loss
  • Growth Hormone
  • Muscle Growth
  • Tissue Repair
  • Recovery
  • Anti-Aging
  • Cognitive
  • Accessories
  • Ships worldwide

  • United Kingdom
  • Australia
  • Canada
  • Canada (FR)
  • Ireland
  • Malta
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Portugal
  • Greece
  • Austria
  • Poland
  • Sweden
  • Finland
  • Denmark
  • Norway
  • Croatia
  • Slovakia
  • Slovenia
  • Estonia
  • Latvia
  • Lithuania
  • Czechia
  • Hungary
  • Romania
  • Bulgaria
  • Belgium
  • Belgium (FR)
  • Luxembourg
  • USA
  • Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

    All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.

    Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

    © 2026 New-U Research Compounds · new-u.io · @new.u.io

    Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.

    © 2026 New-U Research Compounds · new-u.io — Copyright held with Hilxera Distribution Services LLC. All rights reserved.